Date published: 2025-12-21

001 800-1338-3838

SCBT Portrait Logo
Seach Input

KIAA1822L アクチベーター

The term KIAA1822L Activators suggests a class of chemical compounds postulated to interact with a protein encoded by a gene that might be designated as KIAA1822L. The KIAA nomenclature originates from a series of genes identified by the Kazusa DNA Research Institute, where many of these genes were initially cataloged without detailed functional information. The protein KIAA1822L would, therefore, require initial investigative research to determine its cellular role, expression patterns, and biochemical properties. If KIAA1822L activators existed, they would be molecules designed to enhance the activity of this protein, which would involve increasing its expression, activity, stability, or modulating its interactions with other cellular components. The design and discovery process of such activators would likely be initiated by high-throughput chemical screening, aiming to identify compounds that can positively modulate the protein's function. Subsequent validation steps would include verifying the specificity of these activators to ensure that the observed effects are due to direct interaction with the KIAA1822L protein.

Developing a deeper understanding of the interaction between KIAA1822L activators and their target protein would involve a series of advanced analytical techniques. Researchers might employ methods such as affinity chromatography to quantify the binding affinity of the activators, or use mass spectrometry to elucidate the molecular weight and structural features of the protein-activator complexes. Additionally, computational tools like molecular dynamics simulations could predict how the activators affect the protein's structure and function. Nuclear magnetic resonance (NMR) spectroscopy could provide insights into the conformational changes within the protein upon activator binding. Through these methods, scientists would seek to map the activator binding sites, understand the mechanism of activation, and characterize the molecular interactions at play. This detailed molecular characterization would be essential for researchers to fully grasp the biochemical implications of activating the KIAA1822L protein, even though, as of now, such a protein and its corresponding activators are purely speculative and not grounded in the current scientific literature.

関連項目

Items 1 to 10 of 12 total

画面:

製品名CAS #カタログ #数量価格引用文献レーティング

Cyclopamine

4449-51-8sc-200929
sc-200929A
1 mg
5 mg
$92.00
$204.00
19
(1)

Hhシグナル伝達経路の阻害剤であり、代償反応としてHHIPL2をアップレギュレートする可能性がある。

Purmorphamine

483367-10-8sc-202785
sc-202785A
1 mg
5 mg
$56.00
$180.00
18
(1)

Hh経路を活性化し、HHIPL2のような関連遺伝子の発現を増加させる可能性がある。

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$76.00
$150.00
$725.00
$1385.00
$2050.00
73
(3)

cAMPレベルを上昇させ、HHIPL2を含むHh経路遺伝子の発現に影響を及ぼす可能性がある。

Cholecalciferol

67-97-0sc-205630
sc-205630A
sc-205630B
1 g
5 g
10 g
$70.00
$160.00
$290.00
2
(1)

HHIPL2の発現に影響を及ぼす可能性のある、様々な発生および分化経路を調節することができる。

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$65.00
$319.00
$575.00
$998.00
28
(1)

発生過程における遺伝子発現の制御因子であり、HHIPL2の発現に影響を与える可能性がある。

Lithium

7439-93-2sc-252954
50 g
$214.00
(0)

リチウムはWntシグナルを活性化し、間接的にHh経路とHHIPL2の発現に影響を与える可能性がある。

Cholesterol

57-88-5sc-202539C
sc-202539E
sc-202539A
sc-202539B
sc-202539D
sc-202539
5 g
5 kg
100 g
250 g
1 kg
25 g
$26.00
$2754.00
$126.00
$206.00
$572.00
$86.00
11
(1)

コレステロールはHhリガンドの前駆体であり、そのレベルはHh経路のシグナル伝達に影響を与える。

Ketoconazole

65277-42-1sc-200496
sc-200496A
50 mg
500 mg
$62.00
$260.00
21
(1)

ステロール合成を阻害する抗真菌剤で、HHhシグナル伝達を阻害し、HHIPL2の発現に影響を及ぼす可能性がある。

Lovastatin

75330-75-5sc-200850
sc-200850A
sc-200850B
5 mg
25 mg
100 mg
$28.00
$88.00
$332.00
12
(1)

コレステロール合成阻害剤として、スタチンはHh経路、ひいてはHHIPL2の発現を調節する可能性がある。

GANT61

500579-04-4sc-202630
sc-202630A
sc-202630B
1 mg
5 mg
10 mg
$63.00
$128.00
$200.00
6
(1)

Hhシグナル転写因子GLIの特異的阻害剤で、HHIPL2の発現を変化させる可能性がある。